ArticleJournal of hepatology2023

Inhibition of VEGF-B signaling prevents non-alcoholic fatty liver disease development by targeting lipolysis in the white adipose tissue.

Annelie Falkevall et al.PubMed ↗Publisher ↗

No numbers read from the abstract.